pharmacy hardware store illustration

Lonza’s strategy is to be the leading, integrated, value-added solutions provider for the healthcare continuum. We serve markets along this continuum through all of our Pharma&Biotech segment businesses and many of our Specialty Ingredients businesses. Lonza offers a wide range of services and products from the custom development and manufacturing of active pharmaceutical ingredients to innovative dosage forms for the pharma and consumer health and nutrition industries.

We also serve the healthcare continuum with drinking water sanitizers, nutraceuticals, advanced crop-protection and growth product, antidandruff agents and other personal care ingredients, and biocides that deter the growth of mold and bacteria in paints and other coatings, wallboard, plastic bath mats and shower curtains. In addition, we provide disinfectants that combat dangerous viruses, bacteria and other pathogens in everything from nursing homes and hospitals to restaurants, cruise ships and homes.  

In July 2017 Lonza took a major step towards expanding our presence and accelerating growth along the healthcare continuum by acquiring Capsugel. Capsugel designs, develops and manufactures a wide range of innovative dosage forms for the biopharmaceutical and consumer health and nutrition industries. The unique combination of science, engineering, formulation and capsule expertise will enable our customers to optimize the bioavailability, targeted delivery and overall performance of their products – getting us closer to the patient and end consumer.  

We also complemented and strengthened our technological and service leadership in pharma markets with the launch in November 2016 of our Drug Product Services business. This business focuses on one of the most challenging areas in the biopharma industries -- the development, manufacturing and delivery of parenteral products, which encompass medicines and therapies that are injected or infused into patients as well as implantable medical devices.  

In September 2016, Lonza also strengthened our offerings to the healthcare continuum by acquiring InterHealth Nutraceuticals. InterHealth complements Lonza’s existing nutritional portfolio in the area of sports nutrition, weight management, immune health and pet health. Its proprietary UII® joint-health care ingredient, for example, is revolutionizing the treatment of hip, knee and other joint pain and stresses.